Investigating the Impact of Acceptance and Commitment Therapy on Resiliency in Women Affected by Domestic Violence

February 16, 2022 updated by: Fatemeh Khakshoor

This study is a randomized controlled counseling intervention with pre-test, post-test and control groups. After obtaining informed consent from 80 women affected by domestic violence that referred to the health centers of the villages covered by Al-Kooh Mashhad Health Center (Mashhad Al-Kooh Health Center, Michan, Mosleh Abad) and Mashhad Al-Kobeh Health Center, and are eligible to enter Rct are. A woman who has been subjected to domestic violence is someone who has obtained at least one score on the (cts2) questionnaire .

Then, these people are randomly divided into two groups of intervention (n = 40) and control (n = 40). The members of the intervention group in groups of 10 are treated in 8 sessions of 90 minutes once a week based on "acceptance and commitment treatment" based on Hayes (2006) approach by a trained consultant (researcher) in Mashhad AL-koubeh Health Center. The control group also receives 8 counseling sessions once a week by the same "health education" consultant in groups of 10 at the same center. One week after the end of the eighth session and one month later, the questionnaires are completed again by trained questioners for both groups.

The instruments studied in this study include demographic questionnaire, conflict resolution tactics questionnaire (cts 2) and resilience questionnaire (Connor-Davidson). Data analysis is performed using descriptive and inferential statistics with SPSS software version 23.

Study Overview

Detailed Description

Sampling:

In this project, (80 people) eligible women (with at least one score from the CTS2 questionnaire) are selected through available health centers in the villages covered by Mashhad-e-Kobeh Health Center and Mashhad-e-Koboeh Health Center by available sampling method. They are randomly divided into intervention and control groups.

Randomization type:

Randomization is blockchain. 20 blocks with a volume of 4 are used, two allocations for the control group and two allocations for the intervention group. Random sequencing is done using a web-based random site (https://www.sealedenvelope.com).

Sequence Hiding: Sequence hiding is when someone outside the research team has a random assignment list. As soon as a person is eligible to participate in the study, the sampler contacts the person who has a random assignment sequence and he / she gives the code to the participants to enter the study according to the sequence list.

Acceptance and commitment therapy sessions are held by a researcher who has learned the workshop before starting the project. In the evaluation phase, one week and one month after the intervention, the questionnaires are completed by trained questioners. The statistical consultant who will help analyze the data is unaware of the codes of the participants in the groups. Therefore, the study will be of the three-blind type.

Data collection method:

Questionnaires are completed by pre-intervention interviews by trained researchers and samplers and in the evaluation phase after the intervention and follow-up by trained interviewers. Before starting the study, questioners with high public and social relations are selected for sampling and during a session, the necessary training is given to them by the researcher. During the briefing, the objectives of the study and the work process, the sampling method, the confidentiality of customer information and the privacy of the participant, and all ethical principles related to domestic violence research are taught to the samplers.

Data collection tools:

The instruments studied in this study include Demographic Questionnaire, CTS2 Conflict Resolution Tactics Questionnaire (to determine the status of violence) and Connor and Davidson Resilience Questionnaire (to determine the status of resilience).

Hypothesis:

Acceptance and commitment to therapy affect women's resilience to domestic violence.

all purpose: The effect of treatment acceptance and commitment on the resilience of women affected by domestic violence is determined.

Specific objectives:

Determining and comparing the mean resilience score in the intervention and control groups, before, one week after the intervention and one month after the intervention.

Functional purpose:

If the effectiveness of acceptance and commitment therapy in improving the resilience of women affected by domestic violence is confirmed, this intervention method can be used in counseling centers and its use can be taught to service providers, especially midwives. Applying this method will probably be effective in reducing the rate of violence and mutual violence against women, promoting women's health, improving marital relations and marital satisfaction, strengthening the family and reducing the rate of divorce.

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Giving informed written consent.
  • Having experience of domestic violence by the husband for at least the last six months (obtaining at least one grade from the aggressive form of the cts2 questionnaire).
  • Ability to speak Persian.
  • Having at least a third grade of secondary education (to Reason for being able to understand the concepts related to intervention and being able to do homework)
  • Being Iranian.
  • Being married.
  • Not being pregnant during pregnancy and postpartum (up to 6 months postpartum).
  • Not taking psychedelic, anti-anxiety and anti-depressant drugs In the interval of 6 months before participating in the study and during the study.
  • No consciousness disorder.
  • No history of hospitalization in the psychiatric ward.
  • No incurable physical disease such as cancer Or malignant tumors.
  • Not experiencing any severe stress such as divorce, accident, bereavement of relatives in the last six months.
  • No simultaneous participation in counseling courses with content similar to the present intervention.

Exclusion Criteria:

  • Not participating in two or more treatment sessions.
  • Experiencing any severe stress during the study, such as incurable physical illness such as cancer or malignant tumors, pregnancy during the study, divorce, accident, bereavement of relatives.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Acceptance and commitment treatment
The members of the intervention group receive one session of acceptance and commitment treatment per week according to Hayes (2006) approach in groups of 10 in 8 sessions of 90 minutes by a trained counselor (researcher) in Mashhadalkoubeh Health Center.
Investigating the impact of Acceptance and Commitment Therapy on Resiliency in women affected by domestic violence
Sham Comparator: Health Education
This rct has one arm and health education is done only for the purpose of blinding the study so that the participant does not know which of the control or intervention groups it is in and has no comparative aspect and has nothing to do with resilience.
This rct has one arm and health education is done only for the purpose of blinding the study so that the participant does not know which of the control or intervention groups it is in and has no comparative aspect and has nothing to do with resilience

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change of Resiliency
Time Frame: from before the intervention to one week and one month after the intervention
Resilience refers to a person's score on the Connor & Davidson (2003) Questionnaire (CD-RISC).The minimum score on this scale is zero and the maximum score is 100. A higher score indicates more resilience, meaning a better situation.
from before the intervention to one week and one month after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the experience of domestic violence
Time Frame: from before the intervention to one month after the intervention
A violence woman is a woman who has answered at least one question from the (cts2) questionnaire.The minimum score on this scale is zero and the maximum score is 432. A higher score indicates more experience of violence and a worse situation.
from before the intervention to one month after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: abed majidi, phd
  • Study Chair: azam moslemi, phd, Arak University of Medical Sciences
  • Principal Investigator: sakineh taherkhani, phd, Arak University of Medical Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 28, 2020

Primary Completion (Actual)

April 20, 2021

Study Completion (Actual)

June 1, 2021

Study Registration Dates

First Submitted

January 25, 2021

First Submitted That Met QC Criteria

February 13, 2021

First Posted (Actual)

February 17, 2021

Study Record Updates

Last Update Posted (Actual)

February 17, 2022

Last Update Submitted That Met QC Criteria

February 16, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • IR.ARAKMU.REC.1399.226

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Domestic Violence

Clinical Trials on Acceptance and Commitment Therapy

3
Subscribe